The Chronic Kidney Disease Adaptive Platform Trial Investigating Various Agents for Therapeutic Effect

NCT06058585 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

1000

Enrollment

OTHER

Sponsor class

Conditions

Chronic Kidney Diseases

Interventions

DRUG: Finerenone
DRUG: Placebo Finerenone

Sponsor

The George Institute